NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed May 26, 2017
Insider Transaction Report
Form 4
Donigan Heyward R
Director
Transactions
- Exercise/Conversion
Common Stock
2017-04-20$21.73/sh+3,582$77,837→ 3,582 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-04-20−3,582→ 10,784 totalExercise: $21.73From: 2016-08-15Exp: 2023-07-14→ Common Stock (3,582 underlying) - Award
Stock Option (Right to Buy)
2017-05-25+15,643→ 15,643 totalExercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017.